The histone deacetylase SIRT6: At the crossroads between epigenetics, metabolism and disease

Current Topics in Medicinal Chemistry

Volumn 13, Issue 23, 2013, Pages 2991-3000

  Etchegaray, Jean Pierre ^a   Zhong, Lei ^a   Mostoslavsky, Raul ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

Aging; Cancer; Deacetylase; Epigenetics; Glycolysis; Metabolism; SIRT6; Sirtuin

Indexed keywords

HISTONE H3; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA 34A; MICRORNA 766; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PROTEIN C JUN; REACTIVE OXYGEN METABOLITE; SIRTUIN 6; THYMINE DNA GLYCOSYLASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

AGING; ARTICLE; CARCINOGENESIS; COLORECTAL CANCER; DEACETYLATION; DEACYLATION; DNA DAMAGE; DNA REPAIR; ENZYME ACTIVITY; EPIGENETICS; GENOMIC INSTABILITY; GLUCOSE METABOLISM; HEART ATRIUM ENLARGEMENT; HOMEOSTASIS; HOMOLOGOUS RECOMBINATION; HUMAN; INFLAMMATION; LIPID METABOLISM; LIVER CANCER; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; TELOMERE HOMEOSTASIS;

ANIMALS; DISEASE; EPIGENOMICS; HUMANS; SIRTUINS;

EID: 84889053953     PISSN: 15680266     EISSN: 18734294     Source Type: Journal    
DOI: 10.2174/15680266113136660213     Document Type: Article

References (73)

1. Imai, S.; Armstrong, C. M.; Kaeberlein, M.; Guarente, L. Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature, 2000, 403(6771), 795-800.
2. Sinclair, D. A.; Guarente, L. Extrachromosomal rDNA circles-a cause of aging in yeast. Cell., 1997, 91(7), 1033-42.
3. Finkel, T.; Deng, C. X.; Mostoslavsky, R. Recent progress in the biology and physiology of sirtuins. Nature, 2009, 460(7255), 587-91.
4. Haigis, M. C.; Sinclair, D. A. Mammalian sirtuins: biological insights and disease relevance. Annu Rev Pathol., 2010, 5, 253-95.
5. Du, J.; Zhou, Y.; Su, X.; Yu, J. J.; Khan, S.; Jiang, H.; Kim, J.; Woo, J.; Kim, J. H.; Choi, B. H.; He, B.; Chen, W.; Zhang, S.; Cerione, R. A.; Auwerx, J.; Hao, Q.; Lin, H. Sirt5 is a NADdependent protein lysine demalonylase and desuccinylase. Science, 2011, 334(6057), 806-9.
6. Jiang, H.; Khan, S.; Wang, Y.; Charron, G.; He, B.; Sebastian, C.; Du, J.; Kim, R.; Ge, E.; Mostoslavsky, R.; Hang, H. C.; Hao, Q.; Lin, H. SIRT6 regulates TNF-α secretion through hydrolysis of long-chain fatty acyl lysine. Nature, 2013, 496(7443), 110-3.
7. Mostoslavsky, R.; Chua, K. F.; Lombard, D. B.; Pang, W. W.; Fischer, M. R.; Gellon, L.; Liu, P.; Mostoslavsky, G.; Franco, S.; Murphy, M. M.; Mills, K. D.; Patel, P.; Hsu, J. T.; Hong, A. L.; Ford, E.; Cheng, H. L.; Kennedy, C.; Nunez, N.; Bronson, R.; Frendewey, D.; Auerbach, W.; Valenzuela, D.; Karow, M.; Hottiger, M. O.; Hursting, S.; Barrett, J. C.; Guarente, L.; Mulligan, R.; Demple, B.; Yancopoulos, G. D.; Alt, F. W. Genomic instability and aging-like phenotype in the absence of mammalian SIRT6. Cell, 2006, 124(2), 315-29.
8. Kanfi, Y.; Naiman, S.; Amir, G.; Peshti, V.; Zinman, G.; Nahum, L.; Bar-Joseph, Z.; Cohen, H. Y. The sirtuin SIRT6 regulates lifespan in male mice. Nature, 2012, 483(7388), 218-21.
9. Sebastián, C.; Zwaans, B. M.; Silberman, D. M.; Gymrek, M.; Goren, A.; Zhong, L.; Ram, O.; Truelove, J.; Guimaraes, A. R.; Toiber, D.; Cosentino, C.; Greenson, J. K.; MacDonald, AI.; McGlynn, L.; Maxwell, F.; Edwards, J.; Giacosa, S.; Guccione, E.; Weissleder, R.; Bernstein, B. E.; Regev, A.; Shiels, P. G.; Lombard, D. B.; Mostoslavsky, R. The histone deacetylase SIRT6 is a tumor suppressor that controls cancer metabolism. Cell, 2012, 151(6), 1185-99.
10. Sebastián, C.; Satterstrom, F. K.; Haigis, M. C.; Mostoslavsky, R. From sirtuin biology to human diseases: an update. J Biol Chem., 2012, 287(51), 42444-52.
11. Michishita, E.; McCord, R. A.; Berber, E.; Kioi, M.; Padilla-Nash, H.; Damian, M.; Cheung, P.; Kusumoto, R.; Kawahara, T. L.; Barrett, J. C.; Chang, H. Y.; Bohr, V. A.; Ried, T.; Gozani, O.; Chua, K. F. SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature, 2008, 452(7186), 492-6.
12. Michishita, E.; McCord, R. A.; Boxer, L. D.; Barber, M. F.; Hong, T.; Gozani, O.; Chua, K. F. Cell cycle-dependent deacetylation of telomeric histone H3 lysine K56 by human SIRT6. Cell Cycle, 2009, 8(16), 2664-6.
13. Kawahara, T. L.; Michishita, E.; Adler, A. S.; Damian, M.; Berber, E.; Lin, M.; McCord, R. A.; Ongaigui, K. C.; Boxer, L. D.; Chang, H. Y.; Chua, K. F. SIRT6 links histone H3 lysine 9 deacetylation to NF-kappaB-dependent gene expression and organismal life span. Cell, 2009, 136(1), 62-74.
14. Liszt, G.; Ford, E.; Kurtev, M.; Guarente, L. Mouse Sir2 homolog SIRT6 is a nuclear ADP-ribosyltransferase. J Biol Chem., 2005, 280(22), 21313-20.
15. Mao, Z.; Hine, C.; Tian, X.; Van Meter, M.; Au, M.; Vaidya, A.; Seluanov, A.; Gorbunova, V. SIRT6 promotes DNA repair under stress by activating PARP1. Science, 2011, 332(6036), 1443-6.
16. Jiang, H.; Khan, S.; Wang, Y.; Charron, G.; He, B.; Sebastian, C.; Du, J.; Kim, R.; Ge, E.; Mostoslavsky, R.; Hang, H. C.; Hao, Q.; Lin, H. SIRT6 regulates TNF-α secretion through hydrolysis of long-chain fatty acyl lysine. Nature, 2013, 496(7443), 110-3.
17. Mostoslavsky, R. DNA repair; insulin signaling and sirtuins: at the crossroads between cancer and aging. Front Biosci., 2008, 13, 6966-90.
18. Adler, A. S.; Kawahara, T. L.; Segal, E.; Chang, H. Y. Reversal of aging by NFkappaB blockade. Cell Cycle, 2008, 7(5), 556-9.
19. Hotamisligil, G. S. Inflammation and metabolic disorders. Nature, 2006, 444(7121), 860-7.
20. Grimley, R.; Polyakova, O.; Vamathevan, J.; McKenary, J.; Hayes, B.; Patel, C.; Smith, J.; Bridges, A.; Fosberry, A.; Bhardwaja, A.; Mouzon, B.; Chung, C. W.; Barrett, N.; Richmond, N.; Modha, S.; Solari, R. Over expression of wild type or a catalytically dead mutant of Sirtuin 6 does not influence NFκB responses. PLoS One, 2012, 7(7), e39847.
21. Natoli, G. When sirtuins and NF-kappaB collide. Cell, 2009, 136(1), 19-21.
22. Zhong, L.; D'Urso, A.; Toiber, D.; Sebastian, C.; Henry, R. E.; Vadysirisack, D. D.; Guimaraes, A.; Marinelli, B.; Wikstrom, J. D.; Nir, T.; Clish, C. B.; Vaitheesvaran, B.; Iliopoulos, O.; Kurland, I.; Dor, Y.; Weissleder, R.; Shirihai, O. S.; Ellisen, L. W.; Espinosa, J. M.; Mostoslavsky, R. The histone deacetylase Sirt6 regulates glucose homeostasis via Hif1alpha. Cell, 2010, 140(2), 280-93.
23. Yang, B.; Zwaans, B. M.; Eckersdorff, M.; Lombard, D. B. The sirtuin SIRT6 deacetylates H3 K56Ac in vivo to promote genomic stability. Cell Cycle, 2009, 8(16), 2662-3.
24. Das, C.; Lucia, M. S.; Hansen, K. C.; Tyler, J. K. CBP/p300-mediated acetylation of histone H3 on lysine 56. Nature, 2009, 459(7243), 113-7.
25. Yuan, J.; Pu, M.; Zhang, Z.; Lou, Z. Histone H3-K56 acetylation is important for genomic stability in mammals. Cycle, 2009, 8(11), 1747-53.
26. Tjeertes, J. V.; Miller, K. M.; Jackson, S. P. Screen for DNAdamage-responsive histone modifications identifies H3K9Ac and H3K56Ac in human cells. EMBO J., 2009, 28(13), 1878-89.
27. McCord, R. A.; Michishita, E.; Hong, T.; Berber, E.; Boxer, L. D.; Kusumoto, R.; Guan, S.; Shi, X.; Gozani, O.; Burlingame, A. L.; Bohr, V. A.; Chua, K. F. SIRT6 stabilizes DNA-dependent protein kinase at chromatin for DNA double-strand break repair. Aging, 2009, 1(1), 109-21.
28. Maas, N. L.; Miller, K. M.; DeFazio, L. G.; Toczyski, D. P. Cell cycle and checkpoint regulation of histone H3 K56 acetylation by Hst3 and Hst4. Mol Cell., 2006, 23(1), 109-19.
29. Masumoto, H.; Hawke, D.; Kobayashi, R.; Verreault, A. A role for cell-cycle-regulated histone H3 lysine 56 acetylation in the DNA damage response. Nature, 2005, 436(7048), 294-8.
30. Celic, I.; Verreault, A.; Boeke, J. D. Histone H3 K56 hyperacetylation perturbs replisomes and causes DNA damage. Genetics, 2008, 179(4), 1769-84.
31. Li, Q.; Zhou, H.; Wurtele, H.; Davies, B.; Horazdovsky, B.; Verreault, A.; Zhang, Z. Acetylation of histone H3 lysine 56 regulates replication-coupled nucleosome assembly. Cell, 2008, 134(2), 244-55.
32. Xie, W.; Song, C.; Young, N. L.; Sperling, A. S.; Xu, F.; Sridharan, R.; Conway, A. E.; Garcia, B. A.; Plath, K.; Clark, A. T.; Grunstein, M. Histone h3 lysine 56 acetylation is linked to the core transcriptional network in human embryonic stem cells. Mol Cell., 2009, 33(4), 417-27.
33. Toiber, D.; Erdel, F.; Bouazoune, K.; Silberman, D. M.; Zhong, L.; Mulligan, P.; Sebastian, C.; Cosentino, C.; Martinez-Pastor, B.; Giacosa, S.; D'Urso, A.; Näär, A. M.; Kingston, R.; Rippe, K.; Mostoslavsky, R. SIRT6 recruits SNF2H to sites of DNA breaks; preventing genomic instability through chromatin remodeling. Mol. Cell., In Press.
34. Bruzzone, S.; Fruscione, F.; Morando, S.; Ferrando, T.; Poggi, A.; Garuti, A.; D'Urso, A.; Selmo, M.; Benvenuto, F.; Cea, M.; Zoppoli, G.; Moran, E.; Soncini, D.; Ballestrero, A.; Sordat, B.; Patrone, F.; Mostoslavsky, R.; Uccelli, A.; Nencioni, A. Catastrophic NAD+ depletion in activated T lymphocytes through Nampt inhibition reduces demyelination and disability in EAE. PLoS One, 2009, 4(11), e7897.
35. Van Gool, F.; Gallí, M.; Gueydan, C.; Kruys, V.; Prevot, P. P.; Bedalov, A.; Mostoslavsky, R.; Alt, F. W.; De Smedt, T.; Leo, O. Intracellular NAD levels regulate tumor necrosis factor protein synthesis in a sirtuin-dependent manner. Nat Med., 2009, 15(2), 206-10.
36. Wilson, J. P.; Raghavan, A. S.; Yang, Y. Y.; Charron, G.; Hang, H. C. Proteomic analysis of fatty-acylated proteins in mammalian cells with chemical reporters reveals S-acylation of histone H3 variants. Mol. Cell. Proteom., 2011, 10(3), M110. 001198.
37. Zhong, L.; Mostoslavsky, R. SIRT6: a master epigenetic gatekeeper of glucose metabolism. Transcription, 2010, 1(1), 17-21.
38. Warburg, O.; Wind, F.; Negelein, E. The Metabolism of Tumors in the Body. J. Gen. Physiol., 1927, 8(6), 519-30.
39. Dominy, J. E. Jr; Lee, Y.; Jedrychowski, M. P.; Chim, H.; Jurczak, M. J.; Camporez, J. P.; Ruan, H. B.; Feldman, J.; Pierce, K.; Mostoslavsky, R.; Denu, J. M.; Clish, C. B.; Yang, X.; Shulman, G. I.; Gygi, S. P.; Puigserver, P. The deacetylase Sirt6 activates the acetyltransferase GCN5 and suppresses hepatic gluconeogenesis. Mol. Cell., 2012, 48(6), 900-13.
40. Kim, H. S.; Xiao, C.; Wang, R. H.; Lahusen, T.; Xu, X.; Vassilopoulos, A.; Vazquez-Ortiz, G.; Jeong, W. I.; Park, O.; Ki, S. H.; Gao, B.; Deng, C. X. Hepatic-specific disruption of SIRT6 in mice results in fatty liver formation due to enhanced glycolysis and triglyceride synthesis. Cell. Metab., 2010, 12(3), 224-36.
41. Kanfi, Y.; Peshti, V.; Gil, R.; Naiman, S.; Nahum, L.; Levin, E.; Kronfeld-Schor, N.; Cohen H. SIRT6 protects against pathological damage caused by diet-induced obesity. Aging, 2010, 9, 162-173.
42. Ciccia, A.; Elledge, S. J. The DNA damage response: making it safe to play with knives. Mol. Cell., 2010, 40(2), 179-204.
43. Polyakova, O.; Borman, S.; Grimley, R.; Vamathevan, J.; Hayes, B.; Solari, R. Identification of novel interacting partners of Sirtuin6. PLoS One, 2012, 7(12), e51555.
44. Dianov, G. L.; Hübscher, U. Mammalian base excision repair: the forgotten archangel. Nucleic Acids Res., 2013, 41(6), 3483-90.
45. Kaidi, A.; Weinert, B. T; Choudhary, C.; Jackson, S. P. Human SIRT6 promotes DNA end resection through CtIP deacetylation. Science, 2010, 329(5997), 1348-53.
46. Luo, X.; Kraus, W. L. On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1. Genes Dev., 2012, 26(5), 417-32.
47. Xiao, C.; Wang, R. H.; Lahusen, T. J.; Park, O.; Bertola, A.; Maruyama, T.; Reynolds, D.; Chen, Q.; Xu, X.; Young, H. A.; Chen, W. J.; Gao, B.; Deng, C. X. Progression of chronic liver inflammation and fibrosis driven by activation of c-JUN signaling in Sirt6 mutant mice. J. Biol. Chem., 2012, 287(50), 41903-13.
48. Bauer, I.; Grozio, A.; Lasigliè, D.; Basile, G.; Sturla, L.; Magnone, M.; Sociali, G.; Soncini, D.; Caffa, I.; Poggi, A.; Zoppoli, G.; Cea, M.; Feldmann, G.; Mostoslavsky, R.; Ballestrero, A.; Patrone, F.; Bruzzone, S.; Nencioni, A. The NAD+-dependent histone deacetylase SIRT6 promotes cytokine production and migration in pancreatic cancer cells by regulating Ca2+ responses. J. Biol. Chem., 2012, 287(49), 40924-37.
49. Montecucco, F.; Bauer, I.; Braunersreuther, V.; Bruzzone, S.; Akhmedov, A.; Lüscher, T. F.; Speer, T.; Poggi, A.; Mannino, E.; Pelli, G.; Galan, K.; Bertolotto, M.; Lenglet, S.; Garuti, A.; Montessuit, C.; Lerch, R.; Pellieux, C.; Vuilleumier, N.; Dallegri, F.; Mage, J.; Sebastian, C.; Mostoslavsky, R.; Gayet-Ageron, A.; Patrone, F.; Mach, F.; Nencioni, A. Inhibition of nicotinamide phosphoribosyltransferase reduces neutrophil-mediated injury in myocardial infarction. Antioxid. Redox. Signal., 2013, 18(6), 630-41.
50. Heineke, J.; Molkentin, J. D. Regulation of cardiac hypertrophy by intracellular signalling pathways. Nat. Rev. Mol. Cell. Biol., 2006, 7(8), 589-600.
51. Sundaresan, N. R.; Vasudevan, P.; Zhong, L.; Kim, G.; Samant, S.; Parekh, V.; Pillai, V. B.; Ravindra, P. V.; Gupta, M.; Jeevanandam, V.; Cunningham, J. M.; Deng, C. X.; Lombard, D. B.; Mostoslavsky, R.; Gupta, M. P. The sirtuin SIRT6 blocks IGF-Akt signaling and development of cardiac hypertrophy by targeting c-Jun. Nat. Med., 2012, 18(11), 1643-50.
52. Cai, Y.; Yu, S. S.; Chen, S. R.; Pi, R. B.; Gao, S.; Li, H.; Ye, J. T.; Liu, P. Q. Nmnat2 protects cardiomyocites from hypertrophy via activation of SIRT6. FEBS Lett., 2012, 586(6), 866-74.
53. Warburg, O. On the origin of cancer cells. Science, 1956, 123(3191), 309-14.
54. Hanahan, D.; Weinberg, R. A. Hallmarks of cancer: the next generation. Cell, 2011, 144(5), 646-74.
55. van Riggelen, J.; Yetil, A.; Felsher, D. W. MYC as a regulator of ribosome biogenesis and protein synthesis. Nat. Rev. Cancer, 2010, 10(4), 301-9.
56. Min, L.; Ji, Y.; Bakiri, L.; Qiu, Z.; Cen, J.; Chen, X.; Chen, L.; Scheuch, H.; Zheng, H.; Qin, L.; Zatloukal, K.; Hui, L.; Wagner, E. F. Liver cancer initiation is controlled by AP-1 through SIRT6-dependent inhibition of survivin. Nat. Cell. Biol., 2012, 14(11), 1203-11.
57. Van Meter, M.; Mao, Z.; Gorbunova, V.; Seluanov, A. SIRT6 overexpression induces massive apoptosis in cancer cells but not in normal cells. Cell Cycle, 2011, 10(18), 3153-8.
58. Wajant, H.; Pfizenmaier, K.; Scheurich, P. Tumor necrosis factor signaling. Cell Death Differ., 2003, 10(1), 45-65.
59. Varfolomeev, E. E; Ashkenazi, A. Tumor necrosis factor: an apoptosis JuNKie? Cell, 2004, 116(4), 491-7.
60. Wang, L.; Du, F.; Wang, X. TNF-alpha induces two distinct caspase-8 activation pathways. Cell, 2008, 133(4), 693-703.
61. Pham, C. G.; Bubici, C.; Zazzeroni, F.; Papa, S.; Jones, J.; Alvarez, K.; Jayawardena, S.; De Smaele, E.; Cong, R.; Beaumont, C.; Torti, F. M.; Torti, S. V.; Franzoso, G. Ferritin heavy chain upregulation by NF-kappaB inhibits TNFalpha-induced apoptosis by suppressing reactive oxygen species. Cell, 2004, 119(4), 529-42.
62. Chang, L.; Kamata, H.; Solinas, G.; Luo, J. L.; Maeda, S.; Venuprasad, K.; Liu, Y. C.; Karin, M. The E3 ubiquitin ligase itch couples JNK activation to TNFalpha-induced cell death by inducing c-FLIP(L) turnover. Cell, 2006, 124(3), 601-13.
63. Kaeberlein, M.; McVey, M.; Guarente, L. The SIR2/3/4 complex and SIR2 alone promote longevity in Saccharomyces cerevisiae by two different mechanisms. Genes Dev., 1999, 13(19), 2570-80.
64. Haigis, M. C.; Guarente, L. P. Mammalian sirtuins-emerging roles in physiology, aging, and calorie restriction. Genes Dev., 2006, 20(21), 2913-21.
65. Burnett, C.; Valentini, S.; Cabreiro, F.; Goss, M.; Somogyvári, M.; Piper, M. D.; Hoddinott, M.; Sutphin, G. L.; Leko, V.; McElwee, J. J.; Vazquez-Manrique, R. P.; Orfila, A. M.; Ackerman, D.; Au, C.; Vinti, G.; Riesen, M.; Howard, K.; Neri, C.; Bedalov, A.; Kaeberlein, M.; Soti, C.; Partridge, L.; Gems, D. Absence of effects of Sir2 overexpression on lifespan in C. elegans and Drosophila. Nature, 2011, 477(7365), 482-5.
66. Viswanathan, M.; Guarente, L. Regulation of Caenorhabditis elegans lifespan by sir-2. 1 transgenes. Nature, 2011, 477(7365), E1-2.
67. Herranz, D.; Muñoz-Martin, M.; Cañamero, M.; Mulero, F.; Martinez-Pastor, B.; Fernandez-Capetillo, O.; Serrano, M. Sirt1 improves healthy ageing and protects from metabolic syndromeassociated cancer. Nat. Commun., 2010, 12, 1-3.
68. Someya, S.; Yu, W.; Hallows, W. C.; Xu, J.; Vann, J. M.; Leeuwenburgh, C.; Tanokura, M.; Denu, J. M.; Prolla, T. A. Sirt3 mediates reduction of oxidative damage and prevention of age-related hearing loss under caloric restriction. Cell, 2010, 143(5), 802-12.
69. Xiao, C.; Kim, H. S.; Lahusen, T.; Wang, R. H.; Xu, X.; Gavrilova, O.; Jou, W.; Gius, D.; Deng, C. X. SIRT6 deficiency results in severe hypoglycemia by enhancing both basal and insulin-stimulated glucose uptake in mice. J. Biol. Chem., 2010, 285(47), 36776-84.
70. Ladiges, W.; Van Remmen, H.; Strong, R.; Ikeno, Y.; Treuting, P.; Rabinovitch, P.; Richardson, A. Lifespan extension in genetically modified mice. Aging Cell., 2009, 8(4), 346-52.
71. Amor, S.; Puentes, F.; Baker, D.; van der Valk, P. Inflammation in neurodegenerative diseases. Immunology, 2010, 129(2), 154-69.
72. Fischer, R.; Maier, O.; Siegemund, M.; Wajant, H.; Scheurich, P.; Pfizenmaier, K. A TNF receptor 2 selective agonist rescues human neurons from oxidative stress-induced cell death. PLoS One, 2011, 6(11), e27621.
73. Sharma, A.; Diecke, S.; Zhang, W. Y.; Lan, F.; He, C.; Mordwinkin, N. M.; Chua, K. F; Wu, J. C. Role of SIRT6 in Aging and Reprogramming of Human Induced Pluripotent Stem Cells. J. Biol. Chem., 2013, 288(25), 18439-47.